A CMS Rule That Could Steal Your Precious Resource
This fall, the Centers for Medicare and Medicaid Services plans to finalize a proposed rule that risks disincentivizing investment in new cancer treatments
290 Results found
This fall, the Centers for Medicare and Medicaid Services plans to finalize a proposed rule that risks disincentivizing investment in new cancer treatments
The Consumer Choice Center appreciates the chance to comment on Chairman Cassidy's 340B discussion draft. CCC is a nonpartisan consumer advocacy group. We work on policies that lower the prices…
The Consumer Choice Center appreciates the opportunity to respond to the Senate Finance Committee Minority Staff’s Request for Information on lowering prescription drug costs. CCC is a nonpartisan consumer advocacy…
As a Trekkie in the 90s, this phrase first captured my attention when rooting for Captain Picard fighting the Borg collective that aimed to assimilate the entire Alpha Quadrant. Years…
After decades of prescription drug prices rising faster than inflation, new data from the Bureau of Labor Statistics offered some rare positive headlines on affordability. In 2025, prescription drug prices fell by…
Two health announcements landed 48 hours apart last week, and hardly anyone connected them. On Monday, the Emirates Drug Establishment approved a once-daily pill for non-segmental vitiligo, the condition that…
Most-favored-nation drug pricing is usually presented as a clever way to make other countries pay their fair share. Americans pay more for the same medicine than Germans, Canadians or the…
WASHINGTON, D.C. — July 22, 2026 — The Consumer Choice Center (CCC) today warned that the White House's newly announced tariff schedule on generic medicines will raise costs and undermine…
There's a quiet rule change working its way through the Centers for Medicare and Medicaid Services (CMS). Most Americans will never hear about it. But it tells you everything about…
Earlier this year, Dr. Mehmet Oz announced from his perch atop the Centers for Medicare and Medicaid Services that eligible Medicare Part D beneficiaries will be able to access select GLP-1 obesity medicines…
Medical research conferences are not known for wild emotion. They are usually sober, technical gatherings where experts discuss trial design, survival curves, biomarkers, and statistical significance. So when a room…
Voor onmiddellijke publicatie Amsterdam, Nederland — 12 juni 2026 — Een nieuwe peiling in opdracht van het Consumer Choice Center laat zien dat Nederlanders het recht van gewone burgers steunen…